Orchid Pharma receives USFDA approval for rasagiline tablet
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Aurobindo Pharma has received final USFDA approval to manufacture and market pre- surgery sedation injections Dexmedetomidine Hydrochloride in 200 mcg (base)/2 mL (100 mcg (base)/mL) […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Levofloxacin injection, an anti-infective used in the treatment of bacterial infection in adults in […]
Dr. Reddys Laboratories through its subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder. The drug Sernivo […]
Glenmark Pharmaceuticals has received the final USFDA approval for its generic oral contraceptive norgestimate ethinyl estradiol tablets. in strengths of 0.18 mg/0.025 mg, 0.215 mg/ […]
Zydus Cadila has received final USFDA approval to sell anti-diabetics Glyburide and Metformin Hcl tablets in in strengths of 1.25/250, 2.5/500 and 5/500 mg in […]
Glenmark Pharma has received USFDA approval to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets, used to treat migraine headaches. The drug Frovatriptan […]
Unichem Laboratories has received approval from USFDA for its generic Quetiapine Fumarate tablets used for treatment of schizophrenia and bipolar disorder. The approval is for […]
Ajanta Pharma has received final USFDA approval for its generic version of acute migraine pain relief drug almotriptan malate tablets . The company will produce […]
Aurobindo Pharma Ltd has received USFDA approval for acetylcysteine injection. The product is expected to be launched in the first quarter of 2016-17. The drug […]
Copyright © 2024 | WordPress Theme by MH Themes